BIO Events
BIO’s mission to Tokyo builds on fruitful cooperation
The BIO Delegation (pictured from left): Tasuku Kitada (Strand Therapeutics), Adam Roach (BeOne Medicines, formerly Beigene), Jacob Becraft (Strand Therapeutics), John F. Crowley (BIO), Eric ...
March 25, 2025
Read More
Latest News
BIO survey: Tariffs threaten innovation, access to cures
March 31, 2025
BIO’s mission to Tokyo builds on fruitful cooperation
March 25, 2025
LATEST STORIES
Federal Policy
Summit on health care’s future shines light on PBM abuses
We need policy to improve patient access to drugs and address middlemen who increase drug prices, according to participants in a March 27 healthcare conference ...
April 7, 2025
Latest News
How cross-sector collaboration drives rare diseases cures
April is Sarocoidosis Awareness Month, an opportunity to raise awareness, promote understanding and research, and create hope for the affected patients and their families. This ...
April 1, 2025
Federal Policy
Lawmakers should help small biotechs gain capital, BIO Board Member tells House
Appropriate legislation can help innovative biotech firms working on the treatments of the future to build capital, according to congressional testimony from Bill Newell, a ...
March 31, 2025
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIO’s mission to Tokyo builds on fruitful cooperation
The BIO Delegation (pictured from left): Tasuku Kitada (Strand Therapeutics), Adam Roach (BeOne Medicines, formerly Beigene), Jacob Becraft (Strand Therapeutics), John F. Crowley (BIO), Eric ...
March 25, 2025
Read More
M&A comeback may face political headwinds, say BIO CEO panelists
When it comes to biotech M&A, 2024 wasn’t a great year, but it wasn’t “horrible,” according to analysts at the BIO CEO & Investor Conference ...
February 18, 2025
Read More